Ticker Scorecard - CYTK Basics Company: Cytokinetics, Incorporated IPO Date: May 1, 2004 Sector: Healthcare Industry: Biotech Market Cap: $5.73B Activated in VL: True Average Daily Range Avg Daily Range: $0.37 | 2.83% Avg Daily Range (30 D): $0.61 | 1.28% Avg Daily Range (90 D): $0.86 | 1.65% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .86M Avg Daily Volume (90 D): .91M Trade Size Avg Trade Size (Sh.): 92 Avg Trade Size (Sh.) (30 D): 56 Avg Trade Size (Sh.) (90 D): 56 Institutional Trades Total Inst.Trades: 6,490 Avg Inst. Trade: $3.25M Avg Inst. Trade (30 D): $3.68M Avg Inst. Trade (90 D): $3.91M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $6.33M Avg Closing Trade (30 D): $10.08M Avg Closing Trade (90 D): $11.45M Avg Closing Volume: 164.59K     News Jan 6, 2025 @ 9:00 PM Cytokinetics to Present at the 43rd Annual J.P. Mo... Source: Cytokinetics, Incorporated Dec 3, 2024 @ 9:00 PM Cytokinetics Announces Inducement Grants Under Nas... Source: N/A Nov 19, 2024 @ 7:30 AM Cytokinetics and Bayer Announce Exclusive Licensin... Source: N/A Nov 16, 2024 @ 2:00 PM Cytokinetics Presents New Data Relating to Aficamt... Source: N/A Nov 16, 2024 @ 2:00 PM Cytokinetics Presents Additional Data From GALACTI... Source: Cytokinetics, Incorporated Financials   TTM Q3 2024 Q2 2024 Basic EPS $-5.38 $-1.36 $-1.31 Diluted EPS $-5.38 $-1.36 $-1.31 Revenue $ 3.22M $ .46M $ .25M Gross Profit $ $ $ Net Income / Loss $ -576.4M $ -160.55M $ -143.32M Operating Income / Loss $ -524.63M $ -140.8M $ -130.17M Cost of Revenue $ $ $ Net Cash Flow $ -52.8M $ -143.25M $ 70.17M PE Ratio     Splits Jun 25, 2013:   6:1